AC
BIOTW

Antara Capital’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

Antara Capital’s Portfolio BIOTW Stock Details BIOTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-110,000
Closed -$7K – 166
2022
Q4 		$7K Hold
110,000
– – ﹤0.01% 129
2022
Q3 		$7K Hold
110,000
– – ﹤0.01% 167
2022
Q2 		$5K Hold
110,000
– – ﹤0.01% 253
2022
Q1 		$26K Hold
110,000
– – ﹤0.01% 240
2021
Q4 		$72K Buy
+110,000
New +$76.3K ﹤0.01% 189

Antara Capital's BIOTW Position: Q1 2023 in Review

Antara Capital sold out of Biotech Acquisition Company Warrant (BIOTW) in Q1 2023, closing a stake of 110,000 shares — an estimated $7K sold.

Antara Capital first reported a position in BIOTW in Q4 2021 and held it in 5 quarters. The position peaked at $72K in Q4 2021. 0 funds tracked by Wall St. Rank hold BIOTW as of Q1 2023.

  • Antara Capital reported no remaining Biotech Acquisition Company Warrant position as of Q1 2023 after selling out during the quarter.
  • Antara Capital sold 110,000 Biotech Acquisition Company Warrant shares in Q1 2023, an estimated $7K.
  • Antara Capital first reported a position in Biotech Acquisition Company Warrant in Q4 2021 and held it in 5 quarters.
  • Antara Capital's Biotech Acquisition Company Warrant position peaked at $72K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Biotech Acquisition Company Warrant as of Q1 2023.

Based on Antara Capital's 13F filing for Q1 2023, filed 12 May 2023.